Potential Drug Target Or Biomarker: ANTXR1 in Human Tissues (G84168)

Target Name: ANTXR1

NCBI ID: G84168

ANTXR1

Potential Drug Target Or Biomarker: ANTXR1 in Human Tissues

ANTXR1 (ANTR1_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. The protein is derived from the human ANT mouse, which is a strain of mice that have been genetically modified to express human proteins . ANTXR1 is a glycoprotein that consists of two heavy chains and two light chains.

The ANTXR1 protein is expressed in a variety of human tissues, including muscle, heart, brain, and placenta. It is also expressed in the liver, kidneys, and pancreas. The protein is typically expressed at a level of around 100 nanograms per milliliter ( ng/ml) in human tissues.

ANTXR1 has been shown to play a role in a variety of physiological processes in the body. For example, the protein has been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues, and is a potential target for drugs that are designed to intervene in these processes.

ANTXR1 has also been shown to be involved in the regulation of inflammation. The protein has been shown to play a role in the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾. These cytokines can contribute to the inflammatory response that occurs in response to tissue damage or infection.

ANTXR1 has also been shown to be involved in the regulation of cellular apoptosis, which is the process by which cells undergo programmed cell death. The protein has been shown to play a role in the production of apoptotic factors, which can induce apoptosis in cells.

ANTXR1 has been shown to be involved in a variety of diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that ANTXR1 is overexpressed in a variety of cancer tissues, and that inhibition of the ANTXR1 gene has been shown to be effective in treating these conditions.

In addition to its potential clinical applications, ANTXR1 is also a potential biomarker for a variety of diseases. For example, studies have shown that ANTXR1 levels can be used as a diagnostic marker for cancer, neurodegenerative diseases, and other conditions.

Overall, ANTXR1 is a protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in the body and its potential applications in medicine.

Protein Name: ANTXR Cell Adhesion Molecule 1

Functions: Plays a role in cell attachment and migration. Interacts with extracellular matrix proteins and with the actin cytoskeleton. Mediates adhesion of cells to type 1 collagen and gelatin, reorganization of the actin cytoskeleton and promotes cell spreading. Plays a role in the angiogenic response of cultured umbilical vein endothelial cells

The "ANTXR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANTXR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets